Michael B. Hoffman - 17 Nov 2023 Form 4 Insider Report for Annovis Bio, Inc. (ANVS)

Reporting relationship: Director, 10%+ Owner
Issuer ticker: ANVS
Reported as of: 17 Nov 2023
Net transaction value: $0
SEC form: 4
Accepted by SEC: 03 Jul 2024, 17:16:18 UTC
Prior SEC filing: 11 Apr 2023
Next SEC filing: 22 Nov 2023
Source filing: View source filing
Reporting owner signature: /s/ Maria Maccecchini Attorney-in-Fact

Key filing fact

Michael B. Hoffman filed Form 4 for Annovis Bio, Inc. (ANVS) on 03 Jul 2024.

Key facts

This page summarizes Michael B. Hoffman's Form 4 filing for Annovis Bio, Inc. (ANVS).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 03 Jul 2024, 17:16.

Change

Previous filing in this sequence was filed on 11 Apr 2023.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ANVS transaction Derivative

Stock Option (right to buy)

Award

Transaction value: $0
Shares: +29,600
Change %
Price: $0.000000
Shares after: 29,600
Date: 17 Nov 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 29,600
Exercise price: $6.07
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

On June 12, 2024, stockholders of Annovis Bio, Inc. approved an amendment to the 2019 Equity Incentive Plan to increase the number of shares issuable thereunder from 2,000,000 to 3,000,000. 50% of the stock option grant listed was contingent upon the approval of such amendment and would have been forfeited if the amendment had not been approved.

Footnote F2

The stock option shall vest immediately upon grant date.